Table 4 5-, 10-, 15- and 20-year cause-specific survival (CSS) rates, in percentages, estimated by Kaplan-Meier method compared with those estimated by lognormal model [in square brackets] with 95% confidence intervals (in round brackets).
From: Short- and long-term cause-specific survival of patients with inflammatory breast cancer
Years of diagnosis | 5 yr CSS | 10 yr CSS | 15 yr CSS | 20 yr CSS |
|---|---|---|---|---|
1975–77 | 18(16.5–19.4), [20](18.4–21.5) | 11(10.3–11.6), [11](10.3–11.6) | 9(8.4–9.5), [9](8.4–9.5) | 9(8.4–9.5), [8](7.5–8.4) |
1978–80 | 23(21.1–24.8), [24](22.1–25.8) | 16(15.0–16.9), [14](13.1–14.8) | 11(10.3–11.6), [12](11.2–12.7) | 11(10.3–11.6), [11](10.3–11.6) |
1981–83 | 27(24.8–29.1), [30](27.6–32.2) | 18(16.9–19.0), [19](17.8–20.1) | 14(13.1–14.8), [15](14.1–15.8) | NA, [14](13.1–14.8) |
1984–86 | 27(25.4–28.5), [26](24.4–27.5) | 17(16.0–17.9), [18](16.9–19.0) | 15(14.1–15.8), [16](15.0–16.9) | NA, [15](14.1–15.8) |
1987–89 | 27(25.4–28.5), [27](25.4–28.5) | 19(17.8–20.1), [18](16.9–19.0) | NA, [16](15.0–16.9) | NA, [16](15.0–16.9) |
1990–92 | 32(30.1–33.8), [32](30.1–33.8) | 21(19.7–22.2), [22](20.7–23.2) | NA, [19](17.8–20.1) | NA, [18](16.9–19.0) |
1993–95 | 29(27.8–30.1), [29](27.8–30.1) | NA, [21](19.7–22.2) | NA, [20](18.8–21.1) | NA, [20](18.8–21.1) |